Published in World J Gastrointest Surg on January 27, 2016
Updates on antibody-mediated rejection in intestinal transplantation. World J Transplant (2016) 0.76
Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg (2009) 1.21
Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants. Transplantation (2010) 1.13
Transplanting the highly sensitized patient: trials and tribulations. Curr Opin Nephrol Hypertens (2013) 1.09
Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant (2012) 0.97
Novel immunosuppressive agents in kidney transplantation. World J Transplant (2013) 0.96
Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation (2011) 0.95
Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med (2006) 0.94
Living related small bowel transplantation: donor surgical technique. Ann Surg (2004) 0.88
Peak panel reactive antibody, cancer, graft, and patient outcomes in kidney transplant recipients. Transplantation (2015) 0.86
Current status of living donor small bowel transplantation. Curr Opin Organ Transplant (2010) 0.85
Evaluation of c4d deposition and circulating antibody in small bowel transplantation. Am J Transplant (2008) 0.84
Successful isolated intestinal transplantation in sensitized recipients with the use of virtual crossmatching. Am J Transplant (2012) 0.83
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc (2000) 0.82
Antibody-mediated rejection after intestinal transplantation. Curr Opin Organ Transplant (2012) 0.82
Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Clin Transpl (2009) 0.82
Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation. Transpl Int (2014) 0.81
Impact of positive flow cytometry crossmatch on outcomes of intestinal/multivisceral transplantation: role anti-IL-2 receptor antibody. Transplantation (2013) 0.81
Probability of deceased donor kidney transplantation based on % PRA. Transpl Immunol (2013) 0.78
Pretransplant immunomodulation of highly sensitized small bowel transplant candidates with intravenous immune globulin. Transplantation (2006) 0.78